Two molecules of biological interest were labeled in this study: (i) moxestrol, a steroid ligand with a specificity for the estrogen receptor (ER); and (ii) cyclo-RGD, a cyclopeptide targeting the integrin αvβ3 receptors, which are implicated in different forms of cancer. This evidence concerns the gene ESR1 and cancer.